|
National Stock Number(NSN): 6505-01-239-6931 (6505012396931, 012396931)
| NIIN: |
01-239-6931 |
Item Name: |
IOXAGLATE MEGLUMINE AND IOXAGLATE SODIUM |
INC: |
66566
|
| FSC: |
6505
|
Assignment Date: |
Sep-03-1986 |
CRIT: |
X |
IIG: |
66566 |
| ISC: |
5 |
Date Standardized: |
Sep-03-1986 |
HMIC: |
Y |
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
Oct-22-2024 |
PMIC: |
U |
FIIG: |
A45100 |
| ESD: |
|
Schedule B: |
3006.30.0000 |
DEMIL: |
A |
DEMIL INT: |
1 |
| TIIC: |
1 |
Originator: |
97 |
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
5505-042 |
37940
|
MALLINCKRODT INC ANESTHESIA PRODUCTS |
H |
3 |
2 |
6 |
54 |
|
|
|
|
|
|
|
HEXABRIX |
37940
|
MALLINCKRODT INC ANESTHESIA PRODUCTS |
H |
5 |
1 |
6 |
54 |
|
|
|
|
|
|
|
NDC00019-5505-04 |
37940
|
MALLINCKRODT INC ANESTHESIA PRODUCTS |
H |
3 |
2 |
6 |
54 |
|
|
|
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| CQCT |
PRIMARY CONTAINER TYPE |
VIAL |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
30.000 MILLILITERS |
| CSCW |
TOTAL PRIMARY CONTAINER QUANTITY |
25 |
| CSGS |
ADMINISTRATION |
INTRA-ARTERIAL AND INTRAVENOUS |
| FEAT |
SPECIAL FEATURES |
EACH VIAL CONTAINS IOXAGLATE MEGLUMINE 39.3% AND IOXAGLATE SODIUM 19.6%; STERILE |
| MDES |
MEDICAL DESIGNATION AND GRADE |
UNITED STATES PHARMACOPEIA |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| V540 |
|
Apr-01-1991 |
0 |
0 |
|
|
54 |
54 |
|